Recommendations Russian Society of Dermatovenerologists and Cosmetologists&#x0D;
for systemic treatment of psoriasis during the pandemic COVID-19

Кубанов, А. А.; Бакулев, А. Л.; Кохан, М. М.; Olisova, O. Yu; Самцов, А. В.; Sokolovskiy, E. V.; Хайрутдинов, В. Р.; Хобейш, М. М.

doi:10.25208/vdv1129

Vestnik dermatologii i venerologii

2020

DOI: 10.25208/vdv1129

|View full text |Cite

Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19

А. А. Кубанов¹,

А. Л. Бакулев²,

М. М. Кохан³

et al.

Abstract: Below you will find the analysis of the first published data and international clinical recommendations for the systemic treatment of patients with moderate and severe psoriasis in the context of the COVID-19 pandemic in different countries (France, Italy, USA, Spain, and Germany).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A case report of psoriasis exacerbation following COVID-19

Khaliullina

Abdrakhmanov

2021

Kazan Med J

View full text Add to dashboard Cite

The article presents a clinical case of severe exacerbation of psoriasis after a novel coronavirus infection. A 60 years old patient who has recovered from Corona Virus Disease 2019 (COVID-19) was admitted to the Republican Skin and Venereal Disease Dispensary of the Republic of Tatarstan for inpatient treatment with a diagnosis Large plaque psoriasis involving palms and soles. Progressive stage. Scalp psoriasis. Nail psoriasis. This was the first time the patient had experienced psoriasis exacerbation of this severity in his medical history. Presumably, exacerbation of psoriasis was due to the use of hydroxychloroquine. The exacerbation of psoriasis during the pandemic outbreak of Coronavirus disease can be explained by the following reasons: use of hydroxychloroquine, excessive inflammatory response to COVID-19, psychological stress, anxiety, depression, the decline in household income, limited outdoor activities. It is necessary to focus attention of physicians to the fact that patients who have suffered from COVID-19 may develop exacerbation of psoriasis.

show abstract

A case report of psoriasis exacerbation following COVID-19

Khaliullina

Abdrakhmanov

2021

Kazan Med J

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19

Abstract: Below you will find the analysis of the first published data and international clinical recommendations for the systemic treatment of patients with moderate and severe psoriasis in the context of the COVID-19 pandemic in different countries (France, Italy, USA, Spain, and Germany).

Cited by 1 publication

References 7 publications

A case report of psoriasis exacerbation following COVID-19

A case report of psoriasis exacerbation following COVID-19

Contact Info

Product

Resources

About